Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis e virus-like particles

Vaccine

Volumn 22, Issue 3-4, 2004, Pages 370-377

  Li, Tian Cheng ^a   Suzaki, Yuriko ^a   Ami, Yasushi ^a   Dhole, Tapankumar N ^b   Miyamura, Tatsuo ^a   Takeda, Naokazu ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Hepatitis E virus (HEV); Oral immunization; Vaccine; Virus like particles (VLPs)

Indexed keywords

CAPSID PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGICAL ADJUVANT; RECOMBINANT PROTEIN;

AMINO ACID COMPOSITION; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CONTROLLED STUDY; CULTURE MEDIUM; HEPATITIS E; HEPATITIS E VIRUS; INOCULATION; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; VIRUS PARTICLE;

EID: 0344234364     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.08.004     Document Type: Article

References (36)

1. Jameel S. Molecular biology and pathogenesis of hepatitis E virus. Expert reviews in molecular medicine 1999, p. 1-16, http://www-ermm.cbcu.cam.ac. uk .
2. Khuroo M.S. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am. J. Med. 68(6):1980;818-824.
3. Wong D.C., Purcell R.H., Sreenivasan M.A., Prasad S.R., Pavri K.M. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet. 2(8200):1980;876-879.
4. Kane M.A., Bradley D.W., Shrestha S.M.et al. Epidemic non-A, non-B hepatitis in Nepal. Recovery of a possible etiologic agent and transmission studies in marmosets. JAMA. 252(22):1984;3140-3145.
5. Myint H., Soe M.M., Khin T., Myint T.M., Tin K.M. A clinical and epidemiological study of an epidemic of non-A, non-B hepatitis in Rangoon. Am. J. Trop. Med. Hyg. 34:1985;1183-1189.
6. Khuroo M.S., Teli M.R., Skidmore S., Sofi M.A., Khuroo M.I. Incidence and severity of viral hepatitis in pregnancy. Am. J. Med. 70(2):1981;252-255.
7. Balayan M.S. Epidemiology of hepatitis E virus infection. J. Viral Hepat. 4(3):1997;155-165.
8. Schlauder G.G., Dawson G.J., Erker J.C.et al. The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States. J. Gen. Virol. 79(Pt 3):1998;447-456.
9. Erker J.C., Desai S.M., Schlauder G.G., Dawson G.J., Mushahwar I.K. A hepatitis E virus variant from the United States: molecular characterization and transmission in cynomolgus macaques. J. Gen. Virol. 80(Pt 3):1999;681-690.
10. Takahashi K., Iwata K., Watanabe N.et al. Full-genome nucleotide sequence of a hepatitis E virus strain that may be indigenous to Japan. Virology. 287(1):2001;9-12.
11. Meng X.J., Purcell R.H., Halbur P.G.et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc. Natl. Acad. Sci. U.S.A. 94(18):1997;9860-9865.
12. Okamoto H., Takahashi M., Nishizawa T., Fukai K., Muramatsu U., Yoshikawa A. Analysis of the complete genome of indigenous swine hepatitis E virus isolated in Japan. Biochem. Biophys. Res. Commun. 289(5):2001;929-936.
13. Nishizawa T., Takahashi M., Mizuo H., Miyajima H., Gotanda Y., Okamoto H. Characterization of Japanese swine and human hepatitis E virus isolates of genotype IV with 99% identity over the entire genome. J. Gen. Virol. 84(Pt 5):2003;1245-1251.
14. Purcell RH, Emerson SU, Hepatitis E virus. In: Knipe DM, Howley PM, editors. Fields virology, vol. 1. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 3051-61.
15. Balayan M.S., Andjaparidze A.G., Savinskaya S.S.et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 20(1):1983;23-31.
16. Reyes G.R., Purdy M.A., Kim J.P. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 247(4948):1990;1335-1339.
17. Tam A.W., Smith M.M., Guerra M.E.et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology. 185(1):1991;120-131.
18. Bradley D.W., Krawczynski K., Cook E.H. Jr.et al. Enterically transmitted non-A, non-B hepatitis: serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27- to 34-nm viruslike particles. Proc. Natl. Acad. Sci. U.S.A. 84(17):1987;6277-6281.
19. Li T.C., Yamakawa Y., Suzuki K.et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J. Virol. 71(10):1997;7207- 7213.
20. Li T.C., Takeda N., Miyamura T. Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice. Vaccine. 19(2526):2001;3476-3484.
21. Xing L., Kato K., Li T.et al. Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes. Virology. 265(1):1999;35-45.
22. Ball J.M., Hardy M.E., Atmar R.L., Conner M.E., Estes M.K. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J. Virol. 72(2):1998;1345-1353.
23. Ball J.M., Graham D.Y., Opekun A.R., Gilger M.A., Guerrero R.A., Estes M.K. Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology. 117(1):1999;40-48.
24. Purcell R.H., Emerson S.U. Animal models of hepatitis A and E. Ilar J. 42(2):2001;161-177.
25. Tsarev S.A., Emerson S.U., Tsareva T.S.et al. Variation in course of hepatitis E in experimentally infected cynomolgus monkeys. J. Infect. Dis. 167(6):1993;1302-1306.
26. Tsarev S.A., Tsareva T.S., Emerson S.U.et al. Experimental hepatitis E in pregnant rhesus monkeys: failure to transmit hepatitis E virus (HEV) to offspring and evidence of naturally acquired antibodies to HEV. J. Infect. Dis. 172(1):1995;31-37.
27. Uchida T., Win K.M., Suzuki K.et al. Serial transmission of a putative causative virus of enterically transmitted non-A. Jpn. J. Exp. Med. 40:1990;13-21.
28. Aye T.T., Uchida T., Ma X.et al. Sequence and gene structure of the hepatitis E virus isolated from Myanmar. Virus Genes. 7(1):1993;95-109.
29. Li T.C., Zhang J., Shinzawa H.et al. Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus. J. Med. Virol. 62(3):2000;327-333.
30. Supanaranond K., Takeda N., Yamazaki S. The complete nucleotide sequence of a variant of Coxsackievirus A24, an agent causing acute hemorrhagic conjunctivitis. Virus Genes. 6(2):1992;149-158.
31. Tsarev S.A., Emerson S.U., Reyes G.R.et al. Characterization of a prototype strain of hepatitis E virus. Proc. Natl. Acad. Sci. U.S.A. 89(2):1992;559-563.
32. Purdy M.A., McCaustland K.A., Krawczynski K., Spelbring J., Reyes G.R., Bradley D.W. Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV). J. Med. Virol. 41(1):1993;90-94.
33. Tsarev S.A., Tsareva T.S., Emerson S.U.et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc. Natl. Acad. Sci. U.S.A. 91(21):1994;10198-10202.
34. Tsarev S.A., Tsareva T.S., Emerson S.U.et al. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine. 15(17-18):1997;1834-1838.
35. Bryan J.P., Tsarev S.A., Iqbal M.et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J. Infect. Dis. 170(3):1994;517-521.
36. Tsarev S.A., Tsareva T.S., Emerson S.U.et al. Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys. J. Med. Virol. 43(2):1994;135-142.